| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.2 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |